D. Galetta

F. Petrella, A. Borri, M. Casiraghi, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Atypical expression and distribution of embryonic stem cell marker, OCT4, in human lung adenocarcinoma

D. Galetta, L. Spaggiari, R. Schmid, 2010, Journal of surgical oncology.

Sarcomatoid Mesothelioma: Future Advances in Diagnosis, Biomolecular Assessment, and Therapeutic Options in a Poor-Outcome Disease

D. Galetta, A. Catino, A. Misino, 2016, Tumori.

Exploring the Role of Respiratory Microbiome in Lung Cancer: a Systematic Review.

D. Galetta, S. Novello, M. Tiseo, 2021, Critical reviews in oncology/hematology.

Patients’ Attitudes and Physicians’ Perceptions Toward Maintenance Therapy for Advanced Non–Small‐cell Lung Cancer: A Multicenter Italian Survey

A. Rossi, C. Gridelli, A. Ceribelli, 2017, Clinical lung cancer.

Breath Analysis for Early Detection of Malignant Pleural Mesothelioma: Volatile Organic Compounds (VOCs) Determination and Possible Biochemical Pathways

R. Bellotti, S. Tangaro, D. Galetta, 2020, Cancers.

Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features

D. Galetta, S. Novello, F. de Marinis, 2021, Cancers.

Strategies to Improve Cancer Immune Checkpoint Inhibitors Efficacy, Other Than Abscopal Effect: A Systematic Review

V. Longo, D. Galetta, A. Azzariti, 2019, Cancers.

A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer: Accurate review of management and perspectives.

B. Bonanni, G. Pravettoni, D. Galetta, 2018, Critical reviews in oncology/hematology.

Gender Differences and Immunotherapy Outcome in Advanced Lung Cancer

V. Longo, D. Galetta, A. Catino, 2021, International journal of molecular sciences.

Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer.

D. Galetta, A. Cesario, L. Trodella, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Incidental surgical findings of a phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with unresectable non-small cell lung cancer.

D. Galetta, A. Cesario, L. Trodella, 2002, Lung cancer.

Postoperative outcomes of robotic-assisted lobectomy in obese patients with non-small-cell lung cancer.

M. Casiraghi, D. Galetta, A. Tessitore, 2019, Interactive cardiovascular and thoracic surgery.

Endobronchial tumor embolism.

F. Petrella, A. Borri, D. Galetta, 2013, Journal of bronchology & interventional pulmonology.

Robotic assisted lobectomy and lymphadenectomy “different approaches”

M. Casiraghi, D. Galetta, L. Spaggiari, 2018 .

A phase 2 randomized study of TAS-102 versus topotecan or amrubicin in patients requiring second-line chemotherapy for small cell lung cancer refractory or sensitive to frontline platinum-based chemotherapy.

G. Scagliotti, D. Galetta, M. Satouchi, 2016, Lung cancer.

Superior vena cava resection for lung and mediastinal malignancies: a single-center experience with 70 cases.

D. Radice, F. Petrella, D. Galetta, 2007, The Annals of thoracic surgery.

Superior vena cava resection for lung and mediastinal malignancies.

F. Petrella, A. Borri, D. Galetta, 2006, Multimedia manual of cardiothoracic surgery : MMCTS.

Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer

D. Galetta, S. Novello, R. Chiari, 2017, Clinical lung cancer.

Rescue Surgery after Immunotherapy/Tyrosine Kinase Inhibitors for Initially Unresectable Lung Cancer

D. Galetta, L. Spaggiari, F. de Marinis, 2022, Cancers.

Post-operative respiratory rehabilitation after lung resection for non-small cell lung cancer.

D. Galetta, S. Bonassi, S. Sterzi, 2007, Lung cancer.

Advanced resections in minimally invasive surgery: robotic pneumonectomy

M. Casiraghi, D. Galetta, L. Spaggiari, 2019, Shanghai Chest.

Results of thoracoscopic pleural abrasion for primary spontaneous pneumothorax

D. Gossot, D. Galetta, P. Girard, 2004, Surgical Endoscopy And Other Interventional Techniques.

Robotic pneumonectomy

D. Galetta, L. Spaggiari, 2021 .

Ten Years' Experience in Robotic-Assisted Thoracic Surgery for Early Stage Lung Cancer

A. Borri, M. Casiraghi, D. Galetta, 2018, The Thoracic and Cardiovascular Surgeon.

Long-term results of endoscopic thoracic sympathectomy for upper limb hyperhidrosis.

D. Gossot, D. Galetta, Antoine Pascal, 2003, The Annals of thoracic surgery.

[18F]FDG positron emission tomography/computed tomography and multidetector computed tomography roles in thymic lesion treatment planning.

D. Galetta, L. Spaggiari, M. Bellomi, 2008, Lung cancer.

Which factors affect pulmonary function after lung metastasectomy?

F. Petrella, A. Borri, D. Galetta, 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Outcome and prognostic factors of resected non-small-cell lung cancer invading the diaphragm.

F. Petrella, A. Borri, M. Casiraghi, 2013, Interactive cardiovascular and thoracic surgery.

Bronchovascular reconstruction for lung cancer: does induction chemotherapy influence the outcomes?

F. Petrella, A. Borri, D. Galetta, 2012, The Annals of thoracic surgery.

Ten year experience with induction therapy in locally advanced non-small cell lung cancer (NSCLC): is clinical re-staging predictive of pathological staging?

A. D’Andrilli, D. Galetta, A. Cesario, 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Segmentectomy for carcinoid arising from an accessory cardiac bronchus.

A. Borri, D. Galetta, L. Spaggiari, 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

BRMS1 expression in resected lung adenocarcinoma.

V. Longo, D. Galetta, P. Pizzutilo, 2018, Translational lung cancer research.

Systemic Therapy for Oligoprogression in Patients with Metastatic NSCLC Harboring Activating EGFR Mutations

A. Rossi, D. Galetta, 2022, Cancers.

Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: a multi-institutional retrospective analysis.

V. Torri, A. Rossi, D. Galetta, 2011, Lung cancer.

Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial.

G. Fasola, D. Galetta, G. Tortora, 2019, Lung cancer.

The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies.

D. Radice, F. Petrella, A. Borri, 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Prognostic role of lymph node involvement in lung metastasectomy.

F. Petrella, G. Pelosi, D. Galetta, 2007, The Journal of thoracic and cardiovascular surgery.

Staged axillary thoracotomy for bilateral lung metastases: an effective and minimally invasive approach.

D. Galetta, A. Cesario, S. Margaritora, 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

New and old biomarkers in the differential diagnosis of lung cancer: Pro-gastrin-releasing peptide in comparison with neuron-specific enolase, carcinoembryonic antigen, and CYFRA 21-1

D. Radice, D. Galetta, L. Spaggiari, 2019, The International journal of biological markers.

The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients

G. Botti, D. Galetta, L. Crinò, 2019, Cancers.

Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab

D. Galetta, A. Addeo, G. Banna, 2020, Acta oncologica.

Glasgow Prognostic Score Class 2 Predicts Prolonged Intensive Care Unit Stay in Patients Undergoing Pneumonectomy.

D. Radice, F. Petrella, A. Borri, 2016, The Annals of thoracic surgery.

Lymph-node dissection for the treatment of lung cancer: sampling or complete nodal dissection?

D. Galetta, L. Spaggiari, M. Serra, 2008, Lung cancer.

Does chemotherapy increase the risk of respiratory complications after pneumonectomy?

D. Radice, F. Petrella, A. Borri, 2006, The Journal of thoracic and cardiovascular surgery.

Three Cases of Long-Lasting Tumor Control with Erlotinib after Progression with Gefitinib in Advanced Non-Small Cell Lung Cancer

A. Rossi, C. Gridelli, D. Galetta, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Epidermal growth factor receptor exon 19 deletions predict complete regression of multiple intracranial metastases in two cases of non-small cell lung cancer treated with erlotinib.

D. Galetta, L. Crinò, G. Colucci, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study.

A. Rossi, D. Galetta, S. Novello, 2016, Lung cancer.

A Primary Pure Yolk Sac Tumor of the Lung Exhibiting CDX-2 Immunoreactivity and Increased Serum Levels of Alkaline Phosphatase Intestinal Isoenzyme

F. Petrella, G. Pelosi, D. Galetta, 2006, International journal of surgical pathology.

Metachronous primary uterine cancer surgically resected during Crizotinib treatment in a ALK-rearranged advanced lung adenocarcinoma.

G. Serio, D. Galetta, S. Petroni, 2016, Translational lung cancer research.

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

F. Cappuzzo, L. Livi, D. Galetta, 2018, British Journal of Cancer.

Phase II Randomized Study of Vandetanib Plus Gemcitabine or Gemcitabine Plus Placebo as First-Line Treatment of Advanced Non–Small-Cell Lung Cancer in Elderly Patients

S. Barni, A. Brandes, C. Gridelli, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Bladder and Gastric Metastases from Lung Adenocarcinoma Harboring Codon 13 KRAS Mutation: a Case Report with Unusual Clinical Outcome

D. Galetta, A. de Ceglie, G. Simone, 2015, Tumori.

Extended pneumonectomy for non-small cell lung cancer: morbidity, mortality, and long-term results.

D. Radice, F. Petrella, A. Borri, 2007, The Journal of thoracic and cardiovascular surgery.

What Are the Biomarkers for Immunotherapy in SCLC?

D. Ribatti, V. Longo, D. Galetta, 2021, International journal of molecular sciences.

Breath Analysis: A Systematic Review of Volatile Organic Compounds (VOCs) in Diagnostic and Therapeutic Management of Pleural Mesothelioma

D. Galetta, F. Porcelli, G. de Gennaro, 2019, Cancers.

Lung cancer surgery in oligometastatic patients: outcome and survival.

F. Petrella, M. Casiraghi, D. Galetta, 2020, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience.

D. Galetta, A. Ardizzoni, M. Tiseo, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

ROC Analysis Identifies Baseline and Dynamic NLR and dNLR Cut-Offs to Predict ICI Outcome in 402 Advanced NSCLC Patients

D. Galetta, S. Novello, G. Migliaretti, 2020, Journal of Molecular Pathology.

Smoking Prevalence, Knowledge and Perceptions on Tobacco Control Among Healthcare Professionals: A Survey in an Italian Cancer Center

V. Longo, D. Galetta, D. Bafunno, 2020, Journal of community health.

Pre-operative pulmonary rehabilitation and surgery for lung cancer.

D. Galetta, S. Bonassi, S. Sterzi, 2007, Lung cancer.

Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 ≥50% who progress on first-line immunotherapy: real-world data from a European cohort.

D. Galetta, A. Addeo, G. Banna, 2019, Journal of thoracic disease.

Correspondence re L. J. Wirth et al., Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a phase I study. Clin Cancer Res 2003;9:1698-704.

D. Galetta, S. Sterzi, P. Granone, 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

Pandemic Recovery Using a COVID-Minimal Cancer Surgery Pathway

N. Ahuja, D. Boffa, D. Galetta, 2020, The Annals of Thoracic Surgery.

Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy.

D. Galetta, A. Addeo, G. Banna, 2020, Clinical lung cancer.

Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population.

A. Chella, F. Cappuzzo, D. Galetta, 2019, The oncologist.

Successful treatment with three-weekly paclitaxel of an anthracycline-refractory classical Kaposi's sarcoma.

D. Galetta, G. Colucci, N. Silvestris, 2009, Anticancer research.

COPD and abdominal surgery.

D. Galetta, M. Serra, L. Occhionero, 2007, JAMA.

Completion Pneumonectomy for Non-Small-Cell Lung Cancer: Does Induction Treatment Influence Postoperative Outcomes?

D. Galetta, L. Spaggiari, 2022, Cancers.

Complete response following preoperative chemotherapy for resectable non-small cell lung cancer.

D. Galetta, M. Serra, L. Occhionero, 2006, Chest.

Controversial role of mast cells in NSCLC tumor progression and angiogenesis

D. Ribatti, V. Longo, D. Galetta, 2022, Thoracic cancer.

First-line pemetrexed plus cisplatin followed by maintenance pemetrexed versus carboplatin-paclitaxel plus bevacizumab followed by maintenance bevacizumab (ERACLE) in advanced nonsquamous NSCLC: A quality-of-life-oriented, multicenter randomized phase III trial of the GOIM (Gruppo Oncologico Italia

D. Galetta, G. Colucci, E. Maiello, 2013 .

P3.02c-095 Italian Nivolumab Expanded Access Programme: Efficacy and Safety Data in Squamous Non-Small Cell Lung Cancer Patients: Topic: IT Clinical

D. Galetta, L. Crinò, A. Ardizzoni, 2017 .

Incidence of Infections and Predictors of Mortality During Checkpoint Inhibitor Immunotherapy in Patients With Advanced Lung Cancer: A Retrospective Cohort Study

D. Galetta, G. Angarano, F. Di Gennaro, 2021, Open forum infectious diseases.

Concurrent radio-chemotherapy in N2 non small cell lung cancer: interim analysis.

D. Galetta, A. Cesario, S. Margaritora, 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

O-216 Phase III trial comparing cisplatin (CDDP) plus weekly vinorelbine (VNR) and CDDP plus day 1+8 VNR schedules in advanced non small cell lung cancer (NSCLC)

D. Galetta, M. Valerio, G. Colucci, 2003 .

Favourable outcome of coronavirus disease 2019 in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer receiving alectinib

V. Longo, D. Galetta, V. Palmieri, 2020, European journal of cancer.

Favourable outcome of COVID-19 in an ALK-positive NSCLC patient receiving Alectinib

V. Longo, D. Galetta, V. Palmieri, 2020, European Journal of Cancer.

Topoisomerase-1 (topo-I) and thymidylate synthase (TS) primary tumor expression as prognostic and predictive factors for response to cpt-11 in advanced colorectal cancer (crc) patients

A. Paradiso, D. Galetta, A. Zito, 2001 .

Tracheal reconstruction for a long tracheal resection.

D. Galetta, L. Spaggiari, 2006, The Annals of thoracic surgery.

ROC Analysis Identiﬁes Baseline and Dynamic NLR and dNLR Cut-Oﬀs to Predict ICI Outcome in 402 Advanced NSCLC Patients

D. Galetta, S. Novello, G. Migliaretti, 2021, Advanced Biomedicine.

Anterior approach for Pancoast tumor resection.

F. Petrella, A. Borri, D. Galetta, 2007, Multimedia manual of cardiothoracic surgery : MMCTS.

O-090 Weekly vinorelbine plus cisplatin versus day 1+8 vinorelbine withcisplatin in advanced non small cell lung cancer: End results of a phase III trial

D. Galetta, V. Gebbia, M. Caruso, 2005 .

Extrathymic malignancies in patients with thymoma.

D. Galetta, P. Granone, A. Cesario, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Cisplatin, interleukin-2, interferon-α and tamoxifen in metastatic melanoma. A phase II study

D. Galetta, G. Colucci, I. Abbate, 1999 .

Subclavicular recurrence of breast cancer: does surgery play a role?

F. Petrella, G. Pelosi, A. Borri, 2006, Breast.

Surgical Endoscopic Techniques in Patients with Lymphoma

D. Gossot, D. Galetta, 2004 .

Combined small-cell carcinoma of the lung with quadripartite differentiation of epithelial, neuroendocrine, skeletal muscle, and myofibroblastic type

G. Pelosi, D. Galetta, G. Veronesi, 2011, Virchows Archiv.

Topotecan in the treatment of brain metastases. A phase II study of GOIM (Gruppo Oncologico dell'Italia Meridionale).

D. Galetta, G. Colucci, V. Lorusso, 2006, Anticancer research.

Italian clinical research in non-small-cell lung cancer.

A. Rossi, C. Gridelli, D. Galetta, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.

A. Rossi, C. Gridelli, D. Galetta, 2003, Journal of the National Cancer Institute.

Review Article: Pulmonary Sarcomatoid Carcinomas: A Practical Overview

G. Pelosi, D. Galetta, G. Veronesi, 2010, International journal of surgical pathology.

Grading the neuroendocrine tumors of the lung: an evidence-based proposal.

G. Pelosi, M. Papotti, D. Galetta, 2013, Endocrine-related cancer.

Italian Nivolumab Expanded Access Program in Nonsquamous Non–Small Cell Lung Cancer Patients: Results in Never‐Smokers and EGFR‐Mutant Patients

E. Vasile, G. Fasola, D. Galetta, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial.

D. Galetta, G. Colucci, E. Maiello, 2015, Clinical lung cancer.

Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma

Edward S. Kim, I. Wistuba, S. Swisher, 2013, Clinical Cancer Research.

Impact of Cancer Stem Cells and Cancer Stem Cell-Driven Drug Resiliency in Lung Tumor: Options in Sight

D. Galetta, L. Cortes-Dericks, 2022, Cancers.

Farnesyltransferase Inhibitors and Human Malignant Pleural Mesothelioma: A First-Step Comparative Translational Study

D. Galetta, P. Granone, A. Cesario, 2005, Clinical Cancer Research.

RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients.

G. Fontanini, M. Fassan, D. Galetta, 2021, European journal of cancer.

Informative Power Evaluation of Clinical Parameters to Predict Initial Therapeutic Response in Patients with Advanced Pleural Mesothelioma: A Machine Learning Approach

R. Massafra, D. Galetta, A. Fanizzi, 2022, Journal of clinical medicine.

Prognostic value of PET parameters in patients with pleomorphic lung cancer: Results from a single institution.

D. Galetta, L. Spaggiari, L. Travaini, 2021, Lung cancer.

Treatment of advanced non-small cell lung cancer.

G. Scagliotti, C. Gridelli, D. Galetta, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary Sarcoma of Descending Aorta

D. Galetta, A. Tessitore, L. Spaggiari, 2019, Aorta.

Outcomes of First‐Generation EGFR‐TKIs Against Non‐Small‐Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE‐POSITIVE Study

A. Rossi, D. Galetta, S. Novello, 2018, Clinical lung cancer.

Biomarkers for the targeted therapies of non-small cell lung cancer

A. Rossi, D. Galetta, 2012 .

Immunhistochemistry by Means of Widely Agreed-Upon Markers (Cytokeratins 5/6 and 7, p63, Thyroid Transcription Factor-1, and Vimentin) on Small Biopsies of Non-small Cell Lung Cancer Effectively Parallels the Corresponding Profiling and Eventual Diagnoses on Surgical Specimens

G. Pelosi, M. Papotti, G. Rossi, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Biological Prognostic and Predictive Factors in Lung Cancer

A. Rossi, C. Gridelli, D. Galetta, 2010, Oncology.

Original article DOI: 10.1093/annonc/mdh099

D. Galetta, P. Granone, V. Valentini, 2003 .

Surgical management of superior sulcus tumors: A twenty-year experience of an oncological high volume referral centre

F. Petrella, M. Casiraghi, D. Galetta, 2023, Frontiers in Oncology.

Malignant Solitary Fibrous Tumors of the Pleura: Retrospective Review of a Multicenter Series

D. Galetta, L. Spaggiari, P. Graziano, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Giant solitary fibrous tumor of the pleura requiring left pneumonectomy

F. Petrella, A. Borri, M. Casiraghi, 2014, Thoracic cancer.

Solitary fibrous tumours: unusual aspects of a rare disease.

D. Galetta, L. Spaggiari, M. Bellomi, 2012, Hippokratia.

EGFR mutations and HER2/3 protein expression and clinical outcome in Chinese advanced non-small cell lung cancer patients treated with gefitinib

A. Paradiso, Yang Zhang, D. Galetta, 2009, Journal of Cancer Research and Clinical Oncology.

Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumab

D. Galetta, A. Addeo, G. Banna, 2020, Translational lung cancer research.

Induction chemotherapy, extrapleural pneumonectomy and adjuvant radiotherapy for malignant pleural mesothelioma

F. Petrella, M. Casiraghi, D. Galetta, 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Extrapleural Pneumonectomy

D. Galetta, L. Spaggiari, 2020, Definitions.

Final data of an Italian multicentric survey about counseling for smoking cessation in patients with diagnosis of a respiratory disease

D. Galetta, R. Trisolini, S. Novello, 2018, The clinical respiratory journal.

Disparities in subgroup populations enrolled in lung cancer trials

A. Rossi, D. Galetta, G. Palazzolo, 2012, Expert review of respiratory medicine.

High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.

D. Galetta, L. Spaggiari, R. Schmid, 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Peripheral skin edema as unusual toxicity in three patients with advanced non-small cell lung cancer treated with pemetrexed alone or in combination with cisplatin.

D. Galetta, G. Colucci, N. Silvestris, 2011, Journal of Thoracic Oncology.

Pneumocephalus after Pancoast's tumor surgery: to be or not to be conservative?

F. Petrella, A. Borri, D. Galetta, 2007, The Journal of cardiovascular surgery.

The pleural and human fibrin glue sandwich: a quick and effective post-pneumonectomy bronchial stump coverage technique.

D. Galetta, L. Spaggiari, F. Leo, 2008, American journal of surgery.

Bronchopleural Fistula After Pneumonectomy: Risk Factors and Management, Focusing on Open-Window Thoracostomy.

F. Petrella, D. Galetta, R. Gasparri, 2017, Seminars in thoracic and cardiovascular surgery.

WITHDRAWN: Bronchopleural fistula after pneumonectomy: Risk factors and management, focusing on open window thoracostomy.

F. Petrella, D. Galetta, R. Gasparri, 2017, The Journal of thoracic and cardiovascular surgery.

The emerging role of ALK inhibitors in the treatment of advanced non-small cell lung cancer

A. Rossi, D. Galetta, G. Colucci, 2012, Expert opinion on therapeutic targets.

Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.

C. Gridelli, D. Galetta, G. Colucci, 2002, Lung cancer.

Activity of the EGFR-HER2 dual inhibitor afatinib in EGFR-mutant lung cancer patients with acquired resistance to reversible EGFR tyrosine kinase inhibitors.

L. Landi, C. Tibaldi, A. D’Incecco, 2014, Clinical lung cancer.

Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).

D. Galetta, N. Gebbia, G. Colucci, 1997, British Journal of Cancer.

Treatment of stage III-IV non-small-cell lung carcinoma with vinorelbine in combination with ifosfamide plus MESNA: a study by the Southern Italy Oncology Group (GOIM).

D. Galetta, N. Gebbia, G. Colucci, 1996, American journal of clinical oncology.

Enduring challenge in the treatment of nonsmall cell lung cancer with clinical stage IIIB: results of a trimodality approach.

D. Galetta, S. Sterzi, P. Granone, 2003, The Annals of thoracic surgery.

Lung metastases from colorectal cancer: analysis of prognostic factors in a single institution study.

F. Petrella, A. Borri, M. Casiraghi, 2014, The Annals of thoracic surgery.

Upfront pembrolizumab as an effective treatment start in patients with PD-L1 ≥ 50% non-oncogene addicted non-small cell lung cancer and asymptomatic brain metastases: an exploratory analysis

D. Galetta, A. Addeo, F. Roila, 2021, Clinical and Translational Oncology.

M. Filetti, L. Landi, F. Cappuzzo, 2020, Clinical lung cancer.

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%

M. Filetti, L. Landi, F. Cappuzzo, 2020, Cancer Immunology, Immunotherapy.

M. Filetti, D. Galetta, V. Adamo, 2020, medRxiv.

Clinicopathologic correlates of pembrolizumab efficacy in patients with advanced NSCLC and a PD-L1 expression of >= 50%.

M. Filetti, L. Landi, F. Cappuzzo, 2020, medRxiv.

DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non-Small-Cell Lung Cancer: An External Validation.

V. Torri, V. Longo, D. Galetta, 2020, Clinical lung cancer.

EPSILoN: A Prognostic Score Using Clinical and Blood Biomarkers in Advanced Non-Small-cell Lung Cancer Treated With Immunotherapy.

V. Longo, D. Galetta, M. Bilancia, 2020, Clinical lung cancer.

Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients.

A. Rossi, D. Galetta, S. Novello, 2019, Lung cancer.

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

L. Landi, G. Minuti, F. Cappuzzo, 2019, Journal of Immunotherapy for Cancer.

Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non–Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial

A. Chella, L. Landi, G. Alí, 2019, Clinical Cancer Research.

Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes

M. Filetti, D. Galetta, G. Banna, 2019, Clinical and Translational Oncology.

Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study

G. Fontanini, F. Cappuzzo, C. Gridelli, 2014, Journal of Cancer Research and Clinical Oncology.

Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials.

D. Galetta, F. de Marinis, V. Gebbia, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Intercalated Chemotherapy and Epidermal Growth Factor Receptor Inhibitors for Patients With Advanced Non–Small‐cell Lung Cancer: A Systematic Review and Meta‐analysis

A. Rossi, D. Galetta, S. Novello, 2017, Clinical lung cancer.

Management of Italian patients with advanced non-small-cell lung cancer after second-line treatment: results of the longitudinal phase of the LIFE observational study.

G. Fontanini, F. Cappuzzo, C. Gridelli, 2014, Clinical lung cancer.

The impact of personalized medicine on survival: comparisons of results in metastatic breast, colorectal and non-small-cell lung cancers.

V. Torri, A. Rossi, D. Galetta, 2014, Cancer treatment reviews.

Robotic-assisted resection of intralobar and extralobar pulmonary sequestration

D. Galetta, L. Spaggiari, 2022, JTCVS techniques.

Anomalous right upper lobe venous drainage.

D. Galetta, P. Solli, G. Veronesi, 2006, The Annals of thoracic surgery.

Carinal resection: technical tips

F. Petrella, M. Casiraghi, D. Galetta, 2018, Journal of Visualized Surgery.

Carinal resection.

F. Petrella, D. Galetta, L. Spaggiari, 2012, Multimedia manual of cardiothoracic surgery : MMCTS.

Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung.

G. Pelosi, N. Rekhtman, D. Galetta, 2010, Anticancer research.

miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome

D. Galetta, S. Tommasi, R. Lacalamita, 2016, Tumor Biology.

Surgical Techniques and Long-Term Results of Pulmonary Artery Reconstruction in Patients With Lung Cancer.

F. Petrella, A. Borri, D. Galetta, 2015, The Annals of thoracic surgery.

Maintenance or non-maintenance therapy in the treatment of advanced non-small cell lung cancer: that is the question.

A. Rossi, D. Galetta, G. Colucci, 2010, Cancer treatment reviews.

Resectable IIIA-N2 Non-Small-Cell Lung Cancer (NSCLC): In Search for the Proper Treatment

D. Galetta, M. Schiavone, G. Marulli, 2020, Cancers.

Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).

D. Galetta, G. Colucci, V. Lorusso, 2008, Lung cancer.

Early and Long-Term Results of Tracheal Sleeve Pneumonectomy for Lung Cancer After Induction Therapy.

D. Galetta, L. Spaggiari, 2017, The Annals of thoracic surgery.

Video-Thoracoscopic Management of Postpneumonectomy Empyema

D. Galetta, L. Spaggiari, 2018, The Thoracic and Cardiovascular Surgeon.

Thoracoscopic management of postpneumonectomy empyema.

D. Gossot, D. Galetta, P. Girard, 2004, The Annals of thoracic surgery.

Preliminary Results of Extracorporeal Membrane Oxygenation Assisted Tracheal Sleeve Pneumonectomy for Cancer

F. Petrella, M. Casiraghi, D. Galetta, 2020, The Thoracic and Cardiovascular Surgeon.

Right tracheal sleeve pneumonectomy and superior vena cava resection and reconstruction with bovine pericardial patch

F. Petrella, M. Casiraghi, D. Galetta, 2018, ASVIDE.

Carinal resection is performed with an end-to-end anastomosis between the distal trachea and the left main bronchus and an end-to-side anastomosis is performed between the trachea and the right main bronchus

F. Petrella, M. Casiraghi, D. Galetta, 2018, ASVIDE.

Review on bronchopleural fistula: did a surgeon review it?

F. Petrella, A. Borri, D. Galetta, 2006, Chest.

Four-arm robotic lobectomy for the treatment of early-stage lung cancer.

A. Borri, D. Galetta, G. Veronesi, 2010, The Journal of thoracic and cardiovascular surgery.

Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative Review

V. Longo, R. Massafra, D. Galetta, 2023, Journal of clinical medicine.

Minimally invasive technique for bronchoplastic procedure.

D. Galetta, M. Serra, 2002, Chest.

First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.

D. Galetta, G. Colucci, V. Lorusso, 2010, Lung cancer.

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

F. Cappuzzo, L. Livi, D. Galetta, 2018, British Journal of Cancer.

Psychological well-being in cancer outpatients during COVID-19.

V. Longo, D. Galetta, A. Guarini, 2021, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences.

G. Scagliotti, F. Cappuzzo, A. Rossi, 2022, European journal of cancer.

Prognostic factors for survival in extensive‐stage small cell lung cancer: An Italian real‐world retrospective analysis of 244 patients treated over the last decade

V. Longo, D. Galetta, A. Catino, 2022, Thoracic cancer.

Economic burden of patients affected by non-small cell lung cancer (NSCLC): the LIFE study

G. Fasola, D. Galetta, A. Zaniboni, 2017, Journal of Cancer Research and Clinical Oncology.

“Salvage” Surgery for Primary Mediastinal Malignancies: Is it Worthwhile?

D. Radice, F. Petrella, A. Borri, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Efficacy of Pembrolizumab Monotherapy in Patients With or Without Brain Metastases From Advanced Non–Small Cell Lung Cancer With a PD-L1 Expression ≥50%

D. Galetta, A. Addeo, G. Banna, 2020, Journal of immunotherapy.

Extended right pneumonectomy with partial left atrial resection for primary leiomyosarcoma of the mediastinum.

D. Galetta, R. Gasparri, G. Veronesi, 2005, The Journal of thoracic and cardiovascular surgery.

Superior vena cava replacement for lung cancer using a heterologous (bovine) prosthesis: preliminary results.

F. Petrella, G. Pelosi, A. Borri, 2006, The Journal of thoracic and cardiovascular surgery.

Pulmonary metastases: can accurate radiological evaluation avoid thoracotomic approach?

A. D’Andrilli, D. Galetta, P. Granone, 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Unsuspected primary pulmonary meningioma.

D. Galetta, P. Granone, A. Cesario, 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Case report Unsuspected primary pulmonary meningioma

D. Galetta, P. Granone, A. Cesario, 2002 .

Pulmonary inverted Schneiderian papilloma.

D. Galetta, P. Granone, A. Cesario, 2004, The Annals of thoracic surgery.

Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study.

A. Rossi, G. Rossi, A. Ceribelli, 2017, Lung cancer.

Mediastinoscopy as a standardised procedure for mediastinal lymph-node staging in non-small cell carcinoma. Do we have to accept the compromise?

D. Galetta, A. Cesario, S. Margaritora, 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Discordance between FISH, IHC, and NGS Analysis of ALK Status in Advanced Non–Small Cell Lung Cancer (NSCLC): a Brief Report of 7 Cases1

G. Serio, D. Galetta, S. Tommasi, 2018, Translational oncology.

Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.).

D. Galetta, G. Colucci, V. Gebbia, 2005, Anticancer research.

Chest wall resection and reconstruction for locally recurrent breast cancer: From technical aspects to biological assessment.

D. Radice, F. Petrella, A. Borri, 2016, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

Surgery: Indications and Issues

D. Galetta, L. Spaggiari, 2013 .

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.

S. Barni, R. Labianca, G. Luporini, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Robotic Hybrid Approach for an Anterior Pancoast Tumor in a Severely Obese Patient.

Domenico Galetta, Lorenzo Spaggiari, M. Casiraghi, 2018, The Annals of thoracic surgery.

1260MO Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (ICI): Step 1 results of phase III ATALANTE-1 randomised trial

G. Giaccone, D. Galetta, E. Felip, 2020, Annals of Oncology.

ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS).

A. Chella, L. Landi, F. Cappuzzo, 2019, Clinical lung cancer.

Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Grupp

M. Rinaldi, D. Galetta, N. Gebbia, 2003, Lung cancer.

Primary thoracic synovial sarcoma: factors affecting long-term survival.

F. Petrella, G. Pelosi, A. Borri, 2007, The Journal of thoracic and cardiovascular surgery.

Breath Analysis: Comparison among Methodological Approaches for Breath Sampling

P. Barbieri, D. Galetta, G. de Gennaro, 2020, Molecules.

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study

F. Cappuzzo, A. Rossi, D. Galetta, 2019, Clinical and Translational Oncology.

Molecular Profiling of Thin-Prep FNA Samples in Assisting Clinical Management of Non-Small-Cell Lung Cancer

A. Paradiso, D. Galetta, S. Tommasi, 2013, Molecular Biotechnology.

Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE).

D. Galetta, G. Colucci, E. Maiello, 2011, Clinical lung cancer.

Fine Needle Aspiration Cytology: A Tool to Study NHERF1 Expression as a Potential Marker of Aggressiveness in Lung Cancer

Giovanni Simone, Anna Scattone, Domenico Galetta, 2015, Molecular Biotechnology.

Cancer, Heart Diseases, and Common Risk Factors: Smoke

D. Galetta, E. Montagna, A. Catino, 2017 .

Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: a multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603).

D. Galetta, V. Adamo, G. Colucci, 2011, Lung cancer.

Gemcitabine and docetaxel every 2 weeks in advanced non-small cell lung cancer: a phase II study of the Gruppo Oncologico Italia Meridionale.

D. Galetta, G. Colucci, V. Gebbia, 2002, Lung cancer.

Impact of tobacco control interventions on smoking initiation, cessation, and prevalence: a systematic review

V. Longo, D. Galetta, D. Bafunno, 2020, Journal of thoracic disease.

Thymectomy and transpericardial nodal dissection

D. Galetta, L. Spaggiari, 2015, Thoracic cancer.

Completion pneumonectomy: a multicentre international study on 165 patients.

R. Cerfolio, P. V. Van Schil, D. Galetta, 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial.

D. Galetta, V. Valentini, A. Cesario, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Persistent gastric stump-pleural fistula with circumscribed pleural empyema: a single approach for a twofold problem.

D. Galetta, L. Petruzziello, P. Granone, 2004, The Annals of thoracic surgery.

Pulmonary artery reconstruction by a custom-made heterologous pericardial conduit in the treatment of lung cancer.

D. Galetta, G. Veronesi, L. Spaggiari, 2006, Lung cancer.

Tobacco control in Europe: A review of campaign strategies for teenagers and adults.

D. Galetta, D. Bafunno, A. Catino, 2019, Critical reviews in oncology/hematology.

Multimodality treatment of unresectable stage III non-small cell lung cancer: interim analysis of a phase II trial with preoperative gemcitabine and concurrent radiotherapy.

D. Galetta, S. Sterzi, P. Granone, 2006, The Journal of thoracic and cardiovascular surgery.

The therapeutic potential of mesenchymal stem cells in lung cancer: benefits, risks and challenges

D. Galetta, L. Cortes-Dericks, 2019, Cellular Oncology.

Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial

D. Galetta, V. Valentini, A. Cesario, 2002 .

E-36. Long-term results after vertebral body resections for non-small cell lung cancer

D. Gossot, D. Galetta, T. Chevalier, 2003 .

The Role of Immunotherapy or Immuno-Chemotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review

F. Petrella, M. Casiraghi, D. Galetta, 2023, Cancers.

Mediastinal-like growing teratoma syndrome.

G. Pelosi, D. Galetta, R. Gasparri, 2005, The Journal of thoracic and cardiovascular surgery.

Survival after extended resection for mediastinal advanced lung cancer: lessons learned on 167 consecutive cases.

F. Petrella, A. Borri, M. Casiraghi, 2013, The Annals of thoracic surgery.

CT-Guided Percutaneous Radiotracer Localization and Resection of Indistinct/Small Pulmonary Lesions.

M. Casiraghi, D. Galetta, L. Spaggiari, 2019, The Annals of thoracic surgery.

Radio-Guided Localization and Resection of Small or Ill-Defined Pulmonary Lesions.

D. Galetta, L. Spaggiari, M. Bellomi, 2015, The Annals of thoracic surgery.

Results of Surgical Resection of Locally Advanced Pulmonary Neuroendocrine Tumors.

F. Petrella, M. Casiraghi, D. Galetta, 2020, The Annals of thoracic surgery.

Safety evaluation of immune checkpoint inhibitors combined with chemotherapy for the treatment of small cell lung cancer: A meta‐analysis of randomized controlled trials

V. Longo, D. Galetta, Alessandro Rizzo, 2023, Thoracic cancer.

Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study.

A. Rossi, C. Gridelli, A. Ceribelli, 2007, The Lancet. Oncology.

Development of Complex Renal Cysts during Crizotinib Treatment and Also during Alectinib Treatment: A Possible Drug Class Effect?

V. Longo, D. Galetta, P. Gatti, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Atrial Resection without Cardiopulmonary Bypass for Lung Cancer

D. Galetta, L. Spaggiari, 2019, The Thoracic and Cardiovascular Surgeon.

A CT-based transfer learning approach to predict NSCLC recurrence: The added-value of peritumoral region

M. C. Comes, R. Massafra, D. Galetta, 2023, PloS one.

Pneumonectomy in Stage IIIA‐N2 NSCLC: Should It Be Considered After Neoadjuvant Chemotherapy?

C. Gridelli, F. Petrella, M. Casiraghi, 2019, Clinical lung cancer.

Giant alveolar adenoma causing severe dyspnoea.

F. Petrella, G. Pelosi, A. Borri, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Multiple Genetic Alterations as Resistance Mechanism during Second-Line Lorlatinib for Advanced ALK-Rearranged Lung Adenocarcinoma: A Case Report

D. Galetta, S. Tommasi, R. Lacalamita, 2022, Diagnostics.

Second line in NSCLC: new opportunities?

A. Rossi, D. Galetta, 2015 .

Beyond the boundaries: Surgical repair of apical parietal pleural hernia.

D. Galetta, L. Spaggiari, 2019, The Journal of thoracic and cardiovascular surgery.

Apical parietal pleural holes: what are they?

D. Gossot, D. Galetta, M. Serra, 2010, The Thoracic and cardiovascular surgeon.

SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma

D. Galetta, A. Rappa, C. Rampinelli, 2020, Journal of Clinical Pathology.

Intraparenchymal pulmonary artery aneurysm from ipsilobar non-small cell lung cancer.

F. Petrella, A. Borri, D. Galetta, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

How Much Stress Does a Surgeon Endure? The Effects of the Robotic Approach on the Autonomic Nervous System of a Surgeon in the Modern Era of Thoracic Surgery

F. Petrella, M. Casiraghi, D. Galetta, 2023, Cancers.

New stapling devices in robotic surgery.

A. Borri, M. Casiraghi, D. Galetta, 2017, Journal of visualized surgery.

Esophageal Stricture Caused by ALK-Positive NSCLC Esophageal Metastasis Resolved After a Few Days of Lorlatinib Therapy Without Stent Placement

V. Longo, D. Galetta, R. Lacalamita, 2020, JTO clinical and research reports.

Safety profile of erlotinib in patients with advanced non-small cell lung cancer with chronic renal failure.

A. Rossi, C. Gridelli, D. Galetta, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Emergency drain for post pneumonectomy bronchopleural fistula: a drain placement technique based on the siphon principle.

F. Petrella, A. Borri, D. Galetta, 2018, Journal of Thoracic Disease.

circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype‐definition in small cell lung cancer

J. Kjems, A. Fatica, K. Kok, 2022, Genes, chromosomes & cancer.

Successful treatment of triple EGFR mutation T785A/L861Q/H297_E298 with afatinib

V. Longo, D. Galetta, A. Prelaj, 2021, Thoracic cancer.

Long-term results of PRRT in advanced bronchopulmonary carcinoid

C. Tinelli, D. Galetta, N. Fazio, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

A phase II, noncomparative, open label, multicentre, study of AZD9291 in patients with locally advanced or metastatic EGFR mutated “T790M undetectable or unknown” non-small cell lung cancer (stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study).

P. Tassone, D. Galetta, S. Novello, 2017 .

Predicting prolonged air leak after standard pulmonary lobectomy: computed tomography assessment and risk factors stratification.

D. Radice, F. Petrella, A. Borri, 2011, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

Third-Line Therapy for Advanced Non-Small-Cell Lung Cancer Patients: A Feasible Therapeutic Option?

A. Rossi, D. Galetta, G. Colucci, 2010, Oncology.

[18F]FDG PET/CT: Lung Nodule Evaluation in Patients Affected by Renal Cell Carcinoma

D. Galetta, L. Spaggiari, L. Travaini, 2023, Tomography.

Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP1).

D. Galetta, P. Mazzanti, C. Pinto, 2006, Lung cancer.

MA 10.06 Real-World Results in Non-Squamous Non-Small Cell Lung Cancer Patients: Italian Nivolumab Expanded Access Program

D. Galetta, L. Crinò, M. Tiseo, 2017 .

Promising Therapy in Lung Cancer: Spotlight on Aurora Kinases

D. Galetta, L. Cortes-Dericks, 2020, Cancers.

The European Accreditation of Istituto Tumori Giovanni Paolo II of Bari

A. Paradiso, D. Galetta, A. Guarini, 2015, Tumori.

F1 PERIOPERATIVE ANEMIA AND BLOOD TRANSFUSIONS AS PROGNOSTIC FACTORS IN PATIENTS UNDERGOING RESECTION FOR NON-SMALL CELL LUNG CANCERS

D. Galetta, V. Catalano, M., 2005 .

Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study.

M. Filetti, D. Mallardo, P. Ascierto, 2021, JAMA oncology.

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer.

D. Galetta, R. Chiari, G. Tonini, 2018, Future oncology.

Breast Metastasis from Malignant Pleural Mesothelioma: A Rare Challenging Entity.

D. Galetta, D. La Forgia, A. Scattone, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Pneumonectomy with en bloc chest wall resection: is it worthwhile? Report on 34 patients from two institutions.

D. Galetta, L. Spaggiari, F. Facciolo, 2013, Interactive cardiovascular and thoracic surgery.

MA 02.05 Nivolumab in Advanced Non-Squamous NSCLC Patients with KRAS Mutations: Results from the Italian Expanded Access Program (EAP)

L. Landi, L. Livi, D. Galetta, 2017 .

Italian cohort of nivolumab Expanded Access Programme (EAP): Preliminary data from a real-world population.

G. Minuti, D. Galetta, L. Crinò, 2016 .

Primary mediastinal hyalinizing spindle cell tumor with giant rosettes.

D. Galetta, P. Granone, A. Cesario, 2004, The Annals of thoracic surgery.

EP02.04-001 Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-Positive NSCLC: ALNEO Phase II Trial (GOIRC-01-2020)

D. Galetta, F. Mazzoni, L. Boni, 2022, Journal of Thoracic Oncology.

The prognostic value of residual mediastinal involvement following induction therapy and surgery for locally advanced non-small cell lung cancer.

D. Galetta, S. Sterzi, P. Granone, 2004, Lung cancer.

Biological characterization of central and peripheral primary non small cell lung cancers (NSCLC).

D. Galetta, A. Boninsegna, A. Cittadini, 1999, Anticancer research.

Synchronous Robot-Assisted Pulmonary and Urologic Resections for Cancer

D. Galetta, L. Spaggiari, L. Bertolaccini, 2020, Innovations.

The Close Link between Anxiety and Cluster Symptoms in Lung Cancer Patients during First-Line Chemotherapy

A. Rossi, D. Galetta, S. Novello, 2018 .

Safety Analysis of Salvage Surgery for Advanced Stages or Metastatic Lung Cancers

D. Galetta, L. Spaggiari, F. de Marinis, 2021, The Thoracic and Cardiovascular Surgeon.

Thymectomy in myasthenia gravis via video-assisted infra-mammary cosmetic incision.

D. Galetta, A. Cesario, S. Margaritora, 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Focus on cosmesis in thymectomy for myasthenia gravis.

D. Galetta, A. Cesario, S. Margaritora, 2001, Annals of Thoracic Surgery.

Successful subtotal tracheal replacement (using a skin/omental graft) for dehiscence after a resection for thyroid cancer.

D. Galetta, M. Venturino, G. Veronesi, 2005, The Journal of thoracic and cardiovascular surgery.

Neutrophil-to-Lymphocyte Ratio Is a Major Prognostic Factor in Non-small Cell Lung Carcinoma Patients Undergoing First Line Immunotherapy With Pembrolizumab.

C. Gridelli, V. Longo, D. Galetta, 2022, Cancer diagnosis & prognosis.

Pregnancy and heart-lung transplantation.

D. Galetta, O. Baron, J. Michaud, 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.

A. Rossi, C. Gridelli, D. Galetta, 2003, Journal of the National Cancer Institute.

Imaging , Diagnosis , Prognosis Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma

Edward S. Kim, I. Wistuba, S. Swisher, 2013 .

Italian multicenter survey to evaluate the opinion of patients and their reference clinicians on the "tolerance" to targeted therapies already available for non-small cell lung cancer treatment in daily clinical practice.

A. Rossi, D. Galetta, S. Novello, 2014, Translational lung cancer research.

A brief report on survival after robotic lobectomy for early-stage lung cancer.

F. Petrella, M. Casiraghi, D. Galetta, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Natural History of Non-Small-Cell Lung Cancer with Bone Metastases

E. Vasile, S. Barni, D. Galetta, 2015, Scientific Reports.

Role of the contrast-enhanced spectral mammography for the diagnosis of breast metastases from extramammary neoplasms.

S. Tangaro, R. Massafra, D. Galetta, 2019, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Head and Neck Melanoma

D. Galetta, G. Salti, K. Kahnberg, 2012, ISRN surgery.

Vascular Catheter Mimicking Persistent Left Superior Vena Cava

F. Petrella, A. Borri, D. Galetta, 2009, The Thoracic and cardiovascular surgeon.

The elderly patient individualized chemotherapy (EPIC) trial, a study for an aged population of non-small cell lung cancer

V. Torri, G. Scagliotti, D. Galetta, 2019, Annals of Oncology.

Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey

D. Galetta, S. Novello, E. Bria, 2018, Supportive Care in Cancer.

Predictors, surrogate, and patient-reported outcomes in immunotherapy and salvage surgery for unresectable lung cancer: a single-center retrospective study

F. Petrella, M. Casiraghi, D. Galetta, 2023, Updates in Surgery.

Non-small cell lung cancer: from cytotoxic systemic chemotherapy to molecularly targeted therapy.

D. Galetta, P. Granone, A. Cesario, 2004, Current Medicinal Chemistry - Anti-Cancer Agents.

Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line Therapy

V. Longo, D. Galetta, S. Tommasi, 2019, Cancers.

Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Geﬁtinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line Therapy

V. Longo, D. Galetta, S. Tommasi, 2020 .

"Circular clamp" excision: a new technique for lung metastasectomy.

F. Petrella, A. Borri, D. Galetta, 2009, The Journal of thoracic and cardiovascular surgery.

Advances in Lung Cancer Therapy

D. Galetta, 2023, Cancers.

Biochemical modulation of fluorouracil with high dose methotrexate or folinic acid in advanced colorectal cancer patients. Gruppo Oncologico dell' Italia Meridionale (GOIM).

D. Galetta, G. Colucci, E. Maiello, 1994, Anticancer Research.

Activity of the EGFR-HER2 dual inhibitor afatinib in EGFR-mutant lung cancer patients with acquired resistance to reversible EGFR tyrosine kinase inhibitors.

L. Landi, C. Tibaldi, A. D’Incecco, 2014, Clinical lung cancer.

Poor performance status and front-line pembrolizumab in advanced non-small-cell lung cancer (NSCLC) patients with PD-L1>50%.

D. Galetta, A. Addeo, G. Banna, 2020 .

Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumors.

F. Petrella, D. Galetta, R. Gasparri, 2015, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

D. Galetta, G. Colucci, V. Lorusso, 2008, Lung cancer.

Four-arm robotic lobectomy for the treatment of early-stage lung cancer.

A. Borri, D. Galetta, G. Veronesi, 2010, The Journal of thoracic and cardiovascular surgery.

Pneumonectomy for lung cancer: a further step in minimally invasive surgery.

D. Galetta, L. Spaggiari, 2011, The Annals of thoracic surgery.